article · Austin Journal of Clinical Ophthalmology
Chlorpromazine is reported to cause damage to the ocular tissues consisting of fine granulations in the anterior subcapsular layers of the lens and in the posterior surface of the cornea. Vision decline is not noted until advanced stages and patients commonly describe glare and halos. Monitoring cataract is recommended in patients on chlorpromazine for an early detection of this rare side effect that can eventually lead to a surgical intervention. We report the case of a 35-year-old subject with a history of schizophrenia treated with chlorpromazine tablet 400 mg daily for 14 years, presenting with a blurred vision in the left eye. His vision was 8/10 in the left eye and 10/10 in the right eye using Snellen chart.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.26420/austinjclinopthalmol.2023.1150
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
